Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Heather Gustafson

Has grant

Assistant Professor

University of Washington

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Recent Grants

Grant: Open

The IL-18-IFNγ axis predicts response to immunotherapy

Open Date: 2023-02-01

Close Date: 2028-01-31

Grant: Close

SBF-ACS RFA: The IL-18 monocytic cytokine response predicts immunotherapy

Open Date: 2022-01-01

Close Date: 2023-12-31

Grant: Close

The IL-18 monocytic cytokine response predicts immunotherapy

Open Date: 2022-01-01

Close Date: 2023-12-31

Grant: Close

Multimodal Silica Nanoparticles for the Assessment of the Role of Tumor-Associated Macrophages in Breast Carcinoma and Therapy

Open Date: 2011-07-01

Close Date: 2014-12-31

Articles (9)

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Heather Gustafson

Research Interests

Explore related searches

Recent Grants

Articles (9)

Reprogramming engineered autologous T cells to overcome resistance in patients with Merkel cell carcinoma

Challenging Traditional ADME Assumptions for Physiologically Based Pharmacokinetic Models for Intravenous Administration of Iron-Carbohydrate Nanomedicines: Potential Utility of Gold Nanoparticle Models as a Roadmap

Fraternal but not identical twins: HLH and ICANS look a lot alike

Low Peripheral Blood Counts and Elevated Proinflammatory Cytokines Signal a Poor CD19 Chimeric Antigen Receptor T-cell Response in Acute Lymphoblastic Leukemia

Using PBMC-humanized mice to identify optimal autologous CAR T products for maximized efficacy and minimized toxicity at an individual level: a study of CD19, CD22, and CD19x22-specific constructs in multiple PBMC donors

STRIvE-02: A First-in-Human Phase I Study of Systemically Administered B7-H3 Chimeric Antigen Receptor T Cells for Patients With Relapsed/Refractory Solid Tumors

Development of a Novel Solid Tumor-Bearing Humanized Animal Model for Simultaneously Evaluating the Toxicity and Efficacy of Bispecific T Cell Engager

PBMC-Humanized Mouse Model to Assess Individual Variability in Efficacy and Toxicity of Universal CD19 Chimeric Antigen Receptor T Cell Immunotherapy

Abstract 4096: Assessing individual variability in efficacy and toxicity of autologous and allogeneic chimeric antigen receptor T-cell immunotherapy using a PBMC-humanized mouse model

Collaborators (11)

Mallory Taylor

Daniel Chen

David Koelle

Shannon K Oda

Raphael Gottardo

Navin Pinto

Aude Chapuis

Evan Hall

Cecilia Yeung

Paul Nghiem

Shailender Bhatia

Make your next move.